April Private Payrolls Rise 109000 Exceeding Expectations ADP Report Signals Steady Labor Market SoftBank Taps Banks for US IPOs of SB Energy and AI Robotics Spinoff Roze Sources Confirm ASE Technology and WUS Printed Circuit Forge Strategic Alliance for Advanced Packaging Facility in Taiwan Scott Remers Spelling Bee Coaching Business 180Hour Plus 10 of Champion Prize Money Indian Billionaires Accelerate Overseas Acquisitions Amid Domestic Growth Constraints SP 500 Notches Fresh Gains as Tech Surge Offsets Energy Slump PGY Q1 2026 Earnings EPS Surges 263 Above Estimates Amid Strong Performance RILYZ Q1 2024 Earnings Negative EPS Reflects Challenging Quarter for BRC Group Holdings SVCO Q1 2026 Earnings BetterThanExpected Loss Drives Modest Stock Gain BLDR Q1 2026 Earnings EPS Misses Estimates by 284 Stock Edges Higher LEGT Q1 2026 Earnings SPAC Reports Positive EPS Amid Ongoing Merger Search JOBY Q1 2026 Earnings EPS Beat by 39 Highlights Progress in eVTOL Development Path Cardlytics CDLX Inches Up as Key Support Holds A Closer Look at the Recovery Nauticus Robotics Warrants KITTW Stalled at 002 Little Movement Low Visibility Arbe Robotics Warrants ARBEW Slide Over 8 as Price Nears 005 Support Floor Primis Financial Corp FRST Edges Higher Amid Steady Trading Regional Bank Stock Finds Support Pulse Biosciences PLSE Shows Modest Gain as Stock Holds Above Key Support European Commission Fines Temu 200 Million Over Illegal and Dangerous Product Sales AIM ImmunoTech Q1 2026 Earnings WiderthanExpected Loss on Absence of Revenue America Movil AMX Holds Near Support Amid Modest Decline Key Levels in Focus REZI Q1 2026 Earnings Strong EPS Beat Amidst Mixed Market Reaction Design Therapeutics Inc DSGN Q1 2026 Earnings NarrowerThanExpected Loss Highlights Progress in Gene Therapy Pipeline TXNM Q1 2026 Earnings EPS Miss of 314 Disappoints Stock Edges Lower DXC Q1 2026 Earnings EPS Surpasses Estimates Stock Rises 293 IOBT Q3 2025 Earnings Narrower Loss Exceeds Expectations as Pipeline Execution Continues BioVie Inc BIVI Q1 2026 Earnings Narrowing Losses and Clinical Progress Buoy Investor Sentiment Harte Hanks HHS Q2 2025 Earnings Narrow Loss Reported as Stock Inches Higher